Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia

Association and linkage studies have established the importance of the major histocompatibility complex (MHC) in the susceptibility for multiple sclerosis (MS). We carried out a case‐control study to investigate the ancestral haplotype A30B18DR3 and MS in the Nuoro population of Sardinia, which is isolated and genetically distinct from other populations in the Mediterranean basin and characterized by genetic homogeneity, high level of inbreeding, low migration, high prevalence of MS, high frequency of the relevant haplotype, and high past malaria prevalence. Cases and controls were serologically typed for the currently recognized HLA‐A, B, and DR antigens. We used a log‐linear approach to fit a wide class of models. We tested our hypothesis comparing different models via a likelihood ratio test. We overcame the complication due to unknown gametic phase using expectation‐maximization (EM) algorithm as the estimation method. We estimated confidence intervals for odds ratio by using a profile likelihood approach. We found that: (1) the ancestral haplotype A30B18DR3 was associated to MS after allowing for a possible stratification in cases and controls; (2) DR3 allele was conditional independent on disease status, given A30B18 haplotype; (3) there was a tendency for ORs for the high‐risk haplotypes to be higher in the high malaria strata; however, this indication did not achieve statistical significance (P = 0.11). Genet. Epidemiol. 20:271–283, 2001. © 2001 Wiley‐Liss, Inc.

[1]  J. Dausset,et al.  HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. , 2008, Tissue antigens.

[2]  L. Degos,et al.  HLA-A,B,C, Bf and glyoxalase I polymorphisms in a sample of the Kabyle population (Algeria). , 2008, Tissue antigens.

[3]  N. Risch,et al.  A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus , 1998, Nature Genetics.

[4]  C. Carcassi,et al.  HLA-B35 frequency variations correlate with malaria infection in Sardinia. , 1998, Tissue antigens.

[5]  D G Clayton,et al.  Fine genetic mapping using haplotype analysis and the missing data problem , 1998, Annals of human genetics.

[6]  M. Daly,et al.  Genomewide scan of multiple sclerosis in Finnish multiplex families. , 1997, American journal of human genetics.

[7]  B. Weinshenker,et al.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis , 1997, Neurology.

[8]  F. Muntoni,et al.  Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. , 1997, American journal of human genetics.

[9]  S. Sawcer,et al.  Genetic analysis of multiple sclerosis. , 1997, Current neurology and neuroscience reports.

[10]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[11]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[12]  G. Lathrop,et al.  Multiple loci for multiple sclerosis , 1996, Nature Genetics.

[13]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[14]  A. Piazza,et al.  Genetic analysis of Sardinia: I. Data on 12 polymorphisms in 21 linguistic domains , 1996, Annals of human genetics.

[15]  D. F. Roberts,et al.  The History and Geography of Human Genes , 1996 .

[16]  J. Hillert,et al.  Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis , 1995, Journal of Neuroimmunology.

[17]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[18]  E. Granieri,et al.  Epidemiology of multiple sclerosis in Italy and in southern Europe , 1995, Acta neurologica Scandinavica. Supplementum.

[19]  G. Rosati Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: A critical overview , 1994, Annals of neurology.

[20]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[21]  L. V. D. van de Putte,et al.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha , 1994, European journal of immunology.

[22]  C. Carcassi,et al.  HLA structure of the Sardinian population: a haplotype study of 551 families. , 1992, Tissue antigens.

[23]  L. Contu,et al.  A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. , 1992, Tissue antigens.

[24]  C. Carcassi,et al.  Study of HLA segregation in 479 thalassemic families. , 1992, Tissue antigens.

[25]  A. Arnaiz-Villena,et al.  C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2. , 1991, Immunobiology.

[26]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[27]  C. Carcassi,et al.  Diabetes susceptibility in Sardinia , 1991, The Lancet.

[28]  A. Piazza,et al.  Genetic and population structure of four Sardinian villages , 1985, Annals of human genetics.

[29]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[30]  M. Abbal,et al.  HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). , 1982, Tissue antigens.

[31]  C. E. Rogers,et al.  Symbolic Description of Factorial Models for Analysis of Variance , 1973 .

[32]  I. Aiello,et al.  Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. , 1996, Neuroepidemiology.

[33]  D. Grennan,et al.  Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. , 1995, Disease markers.

[34]  A. Piazza,et al.  Human Genomic Diversity in Europe: A Summary of Recent Research and Prospects for the Future , 1993, European journal of human genetics : EJHG.

[35]  C. Carcassi,et al.  A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility. , 1991, Human immunology.

[36]  A. Arnaiz-Villena,et al.  Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population. , 1988, Tissue antigens.